An affinity resin containing the peptide ligand Phe-Leu-Leu-Val-Pro-Leu (FLLVPL) has been developed for the purification of fibrinogen. The ligand was identified by screening a solid-phase combinatorial peptide library using an immunostaining technique. The specific binding of fibrinogen to the ligand has been characterized by isothermal calorimetry and adsorption isotherms and is dominated by both hydrophobic interactions and ionic interactions with the N-terminal free amino group. The effective association constant of fibrinogen was substantially higher when the peptide was immobilized on the resin than in solution; moreover, it increased with increasing peptide density, suggesting a cooperative binding effect. A low ionic strength buffer at pH 4 was used successfully to elute adsorbed fibrinogen from the column with high purity, retention of factor XIII crosslinking activity, and minimal, if any, loss of biological function. This general approach to ligand selection and characterization can be used to develop peptide ligands for the affinity purification of diverse proteins on a large scale.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/bit.10120 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prognostic significance and gene co-expression network of CD16A and FGL2 in gliomas.
Front Oncol
November 2024
Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China.
Article Synopsis
- The CD16A gene and its ligand Fibrinogen-like protein 2 are associated with tumorigenesis in glioma.
- Multiple online databases were utilized to analyze their expression and its relationship with clinical variables, indicating their significant correlation with factors like age and tumor type.
- High levels of CD16A and Fibrinogen-like protein 2 are linked to poor prognosis in glioma patients, suggesting they may be valuable as prognostic biomarkers and targets for therapies.
The FGL-1/LAG-3 Axis is Associated With Disease Course in Alcohol-associated Hepatitis: A Preliminary Report.
J Clin Exp Hepatol
October 2024
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Background: Alcohol-associated hepatitis (AH) has a short-term mortality rate of up to 40% primarily related to impaired hepatocyte regeneration and uncontrolled liver inflammation. The acute phase protein fibrinogen-like protein 1 (FGL-1) produced by hepatocytes stimulates hepatocyte proliferation by autocrine signaling. FGL-1 also is a ligand for the inhibitory T cell receptor lymphocyte activation gene 3 (LAG-3).
View Article and Find Full Text PDFExpression of sPD-L1 levels in an ex vivo liver perfusion model.
Clin Exp Immunol
October 2024
Central Institute of Clinical and Chemical Laboratory Diagnostics, University Hospital of Innsbruck, Anichstr. 35, Innsbruck, Austria.
The programmed cell death protein 1 (PD-1) acts as a central inhibitory immune checkpoint receptor. The soluble form of its primary ligand, sPD-L1, was found to be elevated in serum of patients with cancer, infectious diseases and chronic inflammation. So far, the hepatic origin of sPD-L1 has received relatively little attention and is therefore subject of this study in the context of normothermic machine perfusion (NMP) of liver grafts.
View Article and Find Full Text PDFMolecular dynamics simulations involving different β-propeller mutations reported in Swiss and French patients correlate with their disease phenotypes.
Sci Rep
October 2024
Gene Therapy Laboratory, Department of Integrative Biology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632 014, India.
Integrin αIIbβ3 is the predominant receptor for fibrinogen which mediates platelet aggregation, an important step in hemostasis and thrombosis. Several mutations have been reported in the genes encoding αIIb and β3 subunits among patients with Glanzmann thrombasthenia, of which 177 are in the β-propeller domain. The two subunits form a heterodimer at the interface between β-propeller and β-I domains of αIIb and β3, respectively with their stability critical for intracellular trafficking, surface expression, and ligand binding.
View Article and Find Full Text PDFFibrinogen induces inflammatory responses via the immune activating receptor LILRA2.
Front Immunol
October 2024
Department of Immunology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Ishikawa, Japan.
The leukocyte immunoglobulin-like receptor (LILR) family, a group of primate-specific immunoreceptors, is widely expressed on most immune cells and regulates immune responses through interactions with various ligands. The inhibitory type, LILRB, has been extensively studied, and many ligands, such as HLA class I, have been identified. However, the activating type, LILRA, is less understood.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!